Search Results - "Sehati, Fatemeh"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    COVID-19 Associated Fulminant Myocarditis in a Fully-Vaccinated Female: A Case Report with Clinical Follow-up

    COVID-19 Associated Fulminant Myocarditis in a Fully-Vaccinated Female: A Case Report with Clinical Follow-up by Samimisedeh, Parham, Sehati, Fatemeh, Jafari Afshar, Elmira

    Published in Clinical medicine insights. Case reports (01-01-2023)
    “…Background: Myocarditis is considered a serious adverse event after COVID-19 infection. The risk and severity of myocarditis after COVID-19 disease decreased…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Endothelial nitric oxide synthase Asp298Glu (894G/T) gene polymorphism as a possible risk factor for the coronary slow flow phenomenon among Iranians

    Endothelial nitric oxide synthase Asp298Glu (894G/T) gene polymorphism as a possible risk factor for the coronary slow flow phenomenon among Iranians by Karimi, Yeganeh, Sehati, Fatemeh, Sarreshtedari, Ali, Mirzad, Mina, Khalili, Yasaman, Kiani, Reza, Taheri Bajgan, Elham, Hosseini Moghadam, Maryam, Mehrvarz, Farzaneh, Bakhshandeh, Hooman, Parham, Maryam, Malakootian, Mahshid, Sadeghipour, Parham

    Published in BMC cardiovascular disorders (30-06-2022)
    “…Abstract Background Mounting evidence indicates an association between endothelial dysfunction and the coronary slow flow phenomenon (CSFP). In the present…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    CRT-100.32 A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction Revealed Similar Outcome

    CRT-100.32 A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction Revealed Similar Outcome by Mousavi, Mehdi, Sehati, Fatemeh, Tayebi, Amirhossein, Nayeri, Alireza Dehghan, Movahed, Mohammad Reza

    Published in JACC. Cardiovascular interventions (27-02-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion In Patients Undergoing Primary Percutaneous Coronary Intervention For ST-Elevation Myocardial Infarction

    A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion In Patients Undergoing Primary Percutaneous Coronary Intervention For ST-Elevation Myocardial Infarction by Mousavi, Mehdi, Sehati, Fatemeh, Tayebi, Amirhossein, Nayeri, Alireza Dehghan, Movahed, Mohammad Reza

    Published in Cardiovascular revascularization medicine (01-06-2023)
    “…The use of eptifibatide combined with heparin during percutaneous coronary intervention (PCI) in patients presenting with ST-elevation myocardial infarction…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction Revealed Similar Outcome

    A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction Revealed Similar Outcome by Mousavi, Mehdi, Sehati, Fatemeh, Tayebi, Amirhossein, Nayeri, Alireza Dehghan, Movahed, Mohammad Reza

    Published in Cardiovascular revascularization medicine (01-08-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    COVID-19 Associated Fulminant Myocarditis in a Fully-Vaccinated Female: A Case Report with Clinical Follow-up

    COVID-19 Associated Fulminant Myocarditis in a Fully-Vaccinated Female: A Case Report with Clinical Follow-up by Samimisedeh, Parham, Sehati, Fatemeh, Jafari Afshar, Elmira

    Published in Clinical medicine insights. Case reports (01-01-2023)
    “…BackgroundMyocarditis is considered a serious adverse event after COVID-19 infection. The risk and severity of myocarditis after COVID-19 disease decreased…”
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: